Status:
COMPLETED
White Tea for Prevention of Chemotherapy Induced Mucositis
Lead Sponsor:
Vejle Hospital
Conditions:
Oral Mucositis
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The aim of this study is to determine the effectiveness of mouthwash with white tea in the prevention of paclitaxel induced oral mucositis in women with breast cancer.
Detailed Description
Oral mucositis is a common side effect from paclitaxel treatment. It can be very painful and compromise nutrition and oral hygiene, and it may increase the risk of infection. Although oral mucositis i...
Eligibility Criteria
Inclusion
- Woman with breast cancer
- Planned neoadjuvant or adjuvant paclitaxel treatment
- Age ≥ 18 years
- Understand and speak Danish
- Written and orally informed consent
Exclusion
- \- Palliative treatment with paclitaxel
Key Trial Info
Start Date :
September 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04440930
Start Date
September 2 2020
End Date
April 30 2023
Last Update
September 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Oncology, Vejle Hospital
Vejle, Denmark